10P Tumor-infiltrating lymphocytes and tertiary lymphoid structures in oral cavity squamous cell carcinoma in non-smokers and non-drinkers: Predict clinical outcome
Background: Clear cell renal cell carcinoma (ccRCC), accounting for 80% of renal cell carcinoma (RCC) cases, is a common and deadly urological cancer.Only a small proportion of ccRCC patients obtain durable benefits from immunotherapy.Therefore, exploring novel predictive biomarkers for immunotherapy would be beneficial in guiding personalized clinical management for ccRCC patients.
Authors
- Israa Laklouk (ORCID: https://orcid.org/0000-0001-9688-3167)
Publication Details
- Journal
- Immuno-Oncology Technology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1016/j.iotech.2024.100893
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00